Talphera, Inc.
Talphera, Inc.（TLPH）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · TLPH · 截至 2025年9月30日
股东结构概览
38
机构持有人数
▲ 7 vs Q2
$15.88M
机构持仓总市值
▲ $13.45M vs Q2
20.52M
总流通股
freeFloat 62.21%
17.78M
13F 申报持股数
▲ 12.50M vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
TLPH 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
AIGH CAPITAL MANAGEMENT LLC pharmaceutical preparations | 4.45M | 12.90% | 12.90% | $3.98B | Oct 31, 2025 | NEW |
ROSALIND ADVISORS, INC. pharmaceutical preparations | 4.39M | 12.70% | 12.70% | $3.92B | Nov 13, 2025 | ▲ 2.38M |
ROCK SPRINGS CAPITAL MANAGEMENT LP pharmaceutical preparations | 3.59M | 10.39% | 10.39% | $3.21B | Nov 14, 2025 | ▲ 3.27M |
NANTAHALA CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 3.49M | 10.11% | 10.11% | $3.12B | Nov 14, 2025 | ▲ 1.50M |
BLEICHROEDER LP pharmaceutical preparations | 881.2K | 2.55% | 2.55% | $787.06M | Nov 14, 2025 | ▲ 454.5K |
VANGUARD GROUP INC pharmaceutical preparations | 286.2K | 82.89% | 82.89% | $256.75M | Nov 7, 2025 | ▲ 204.9K |
CAPTION MANAGEMENT, LLC pharmaceutical preparations | 250.0K | 72.40% | 72.40% | $223.30M | Nov 14, 2025 | NEW |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 165.7K | 47.98% | 47.98% | $148.70M | Nov 12, 2025 | ▲ 299 |
DAUNTLESS INVESTMENT GROUP, LLC pharmaceutical preparations | 100.0K | 28.96% | 28.96% | $89.32M | Nov 14, 2025 | NEW |
VALUES FIRST ADVISORS, INC. pharmaceutical preparations | 97.9K | 28.35% | 28.35% | $87.43M | Oct 21, 2025 | ▼ 1.3K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
13
增持
+7.93M 股9
新建仓
首次建仓4
减持
−1.6K 股4
清仓
完全退出净股数变化（前50家）
+7.93M
+7.93M / −1.6K
净新增持仓人
+14
新建 9 个 / 退出 4 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
TLPH 内幕交易记录
数据来源：SEC Form 4
近期内部人员净买入。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
0
买入笔数
5
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Aslam Shakil Chief Medical Officer | May 20, 2026 | Tax Withhold | 4,518 | $0.82 | $3.7K | 76.5K | Form 4 ↗ |
Angotti Vincent J. CHIEF EXECUTIVE OFFICER | Apr 2, 2026 | Tax Withhold | 9,938 | $0.72 | $7.2K | 790.8K | Form 4 ↗ |
ASADORIAN RAFFI Chief Financial Officer | Apr 2, 2026 | Tax Withhold | 2,444 | $0.72 | $1.8K | 85.9K | Form 4 ↗ |
Aslam Shakil Chief Medical Officer | Apr 2, 2026 | Tax Withhold | 2,118 | $0.72 | $1.5K | 81.1K | Form 4 ↗ |
Dasu Badri N Chief Engineering Officer | Apr 2, 2026 | Tax Withhold | 2,444 | $0.72 | $1.8K | 71.4K | Form 4 ↗ |
Angotti Vincent J. CHIEF EXECUTIVE OFFICER | Mar 13, 2026 | Purchase | 213,310 | $0.59 | $125.0K | 800.7K | Form 4 ↗ |
Nantahala Capital Management, LLC See remarks | Mar 13, 2026 | Award | 4,266,211 | $0.00 | $4.3K | 18.82M | Form 4 ↗ |
Angotti Vincent J. CHIEF EXECUTIVE OFFICER | Feb 12, 2026 | Award | 594,000 | $0.81 | $482.5K | 594.0K | Form 4 ↗ |
Angotti Vincent J. CHIEF EXECUTIVE OFFICER | Feb 12, 2026 | Purchase | 105,364 | $0.81 | $85.6K | 587.0K | Form 4 ↗ |
Angotti Vincent J. CHIEF EXECUTIVE OFFICER | Feb 14, 2026 | Tax Withhold | 9,559 | $0.79 | $7.6K | 577.4K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Talphera, Inc.（TLPH）主要由机构投资者持有，机构持股比例约为 86.7%。公司内部人员持股约 37.79%，散户及公众持股约占剩余的 0.00%。
Talphera, Inc. 最大机构股东为 AIGH CAPITAL MANAGEMENT LLC，截至 September 30, 2025 持有约 4.45 million 股，占总流通股的 12.90%。
目前共有 38 家机构持有 TLPH 股票，合计持仓市值约 $15,882,410，数据来源为最新 SEC 13F 申报。
常见问题
TLPH ownershipTalphera, Inc.（TLPH）主要由机构投资者持有，机构持股约 86.7%。最大股东为 AIGH CAPITAL MANAGEMENT LLC，持股比例 12.90%。内部人员持股约 37.79%。数据来源 SEC Form 13F，截至 September 30, 2025。